[1] Koltin,Y,Hitchcock CA.The search for new triazole antifungal agents[J].Curr Opin Chem Biol,1997,1(2):176.
[2] 陈平.抗真菌药物的不良反应[J].医师进修杂志,2005,28(11):12.
[3] Plempel M. Experience,recognitions and questions in azole antimycotics[J]. Jpn Med Mycol,1982,23 (1):17.
[4] Wilkinson CF,Krystyna H. Structure-activity relationships in the effects of 1-alkylimidazoles on microsomal oxidation in vitro and in vivo[J].Biochem Pharmacol,1974,23 (17):2377.
[5] Chai XY,Zhang J,Yu SC,et al.Design,synthesis,and biological evaluation of novel 1-(1H-1,2,4-triazole-1-yl)-2-(2,4-difluorophenyl)-3-substituted benzylamin-2-propanols[J].Bioorg Med Chem Lett,2009,19(6):1811.
[6] 吴义杰,周旭,张大志,等.三唑类化合物的合成及其抗真菌活性Ⅱ[J]. 中国药物化学杂志,1998,8(4):235.
[7] Shi W, Nacev BA,Bhat S,et al.Impact of Absolute Stereochemistry on the Antiangiogenic and Antifungal Activities of Itraconazole[J]. ACS Med Chem Lett,2010,1:155.
[8] Saksena AK,Cooper AB,Guzik H,et al.2,4,4,4-tetra substituted-1,3-dioxolane compounds[P].US,WO 88/05048,1988-07-14.
[9] Camps P,Farrés X,García Ma L,et al.Steroselective syntheses of (+)-and (-)- terconazole[J].Tetrahedron:Asymmetry,1995,6(9):2365.
[10] National Committee for Clinical Laboratory Standards.Reference method for broth dilution antifungal susceptibility testing of yeast,Approved standard.Document M27-A3[S].PA:Wayne:2009.
[11] National Committee for Clinical Laboratory Standards.Reference method for broth dilution antifungal susceptibility testing of yeast,Approved Standard.Document M38-A2[S]. PA:Wayne:2008.